Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Cisplatin liposomal - Regulon

Next Previous
X
Search
Drug Profile

Cisplatin liposomal - Regulon

Alternative Names: Lipoplatin; Nanoplatin for NSCLC - Regulon

Latest Information Update: 12 Jan 2022

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Regulon
  • Developer Centre Hospitalier Universitaire Vaudois; Regulon
  • Class Antineoplastics; Platinum complexes; Small molecules
  • Mechanism of Action DNA cross linking agents; DNA synthesis inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Pancreatic cancer
  • New Molecular Entity No

Highest Development Phases

  • Phase III Non-small cell lung cancer
  • Phase II/III Pancreatic cancer
  • Phase II Gastric cancer
  • Discontinued Bladder cancer; Breast cancer; Glioblastoma; Head and neck cancer; Malignant pleural effusion; Ovarian cancer

Most Recent Events

  • 27 Sep 2021 Discontinued - Phase-I for Malignant pleural effusion in Switzerland (IV)
  • 27 Sep 2021 Discontinued - Phase-II for Bladder cancer in Greece (IV)
  • 27 Sep 2021 Discontinued - Phase-II for Breast cancer (Combination therapy, Late-stage disease) in Greece (IV)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top